
    
      Multicenter, prospective, non-randomized, single-arm, observational trial. Subjects will be
      evaluated at 5, 7, 9, and 11 years post-implant. Up to two hundred fifty (250) total subjects
      at up to fifteen (15) investigational sites will be enrolled.
    
  